Deletion of protein kinase C θ attenuates hepatic ischemia/reperfusion injury and further elucidates its mechanism in pathophysiology

Articles in Press

Document Type : Original Article

Authors

1 Department of Pathophysiology, Wannan Medical College, Wuhu, China

2 School of Medical Imaging, Wannan Medical College, Wuhu, China

3 School of Clinical Medicine, Wannan Medical College, Wuhu, China

4 Department of Immunology, Wannan Medical College, Wuhu, China

10.22038/ijbms.2024.77365.16730

Abstract

Objective(s): Hepatic ischemia-reperfusion (HIR) is a severe process in pathophysiology that occurs clinically in hepatectomy, and hepatic transplantations. The present study aimed to investigate the effect of PKC θ deletion against HIR injury and elucidate its mechanism in pathophysiology.
Materials and Methods: HIR injury was induced in wild-type and PKC θ deletion mice treated with or without heme.  The ALT and AST levels were determined to evaluate liver function. HIR injury was observed via histological examination. Oxidative stress and inflammatory response markers, and their signaling pathways were detected.
Results: The study found that PKC θ knockout decreased serum AST and ALT levels when compared to the WT mice. Furthermore, heme treatment significantly reduced the ALT and AST levels of the PKC θ deletion mice compared with the untreated PKC θ deletion mice. PKC θ deletion markedly elevated superoxide dismutase activity in the liver tissue, reduced malondialdehyde content in the tissue, and the serum TNF-α and IL-6 levels compared with the WT mice. Heme treatment was observed to elevate the activity of SOD and reduced MDA content and serum of TNF-α and IL 6 in the PKC θ deletion animals. Meanwhile, heme treatment increased HO-1 and Nrf 2 protein expression, and reduced the levels of TLR4, phosphorylated NF-κB, and IKB-α.
Conclusion: These findings suggested that PKC θ deletion ameliorates HIR, and heme treatment further improves HIR, which is related to regulation of PKC θ deletion on Nrf 2/HO-1 and TLR4/NF-κB/IKB α pathway.

Keywords

Main Subjects

References

1. Simillis C, Robertson FP, Afxentiou T, Davidson BR, Gurusamy KS. A network meta-analysis comparing perioperative outcomes of interventions aiming to decrease ischemia reperfusion injury during elective liver resection. Surgery 2016; 159:1157-1169.
2. Gendy A, Elnagar MR, Soubh A, Al-Mokaddem A, El-Haddad A, El-Sayed MK. Morin alleviates hepatic ischemia/reperfusion-induced mischief: In vivo and in silico contribution of Nrf2, TLR4, and NLRP3. Biomed Pharmacother 2021; 138 :111539-111550.
3. Li J, Li RJ, Lv GY, Liu HQ. The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci 2015; 19:2036-2047.
4. Dickson I. Improving hepatic ischaemia-reperfusion injury outcomes. Nat Rev Gastroenterol Hepatol 2019; 16:583-583.
5. Huang M, Cai H, Han B, Xia YH, Kong XN, Gu JY. Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury. Front Immunol 2022; 13 :870038-870044.
6. He ZG, Ma C, Yu TY, Song J, Leng J, Gu XB, et al. Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury. Exp Cell Res 2019; 376:227-235.
7. Song X, Qian XQ, Shen M, Jiang R, Wagner MB, Ding GL, et al. Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression. Biochim Biophys Acta Mol Cell Res 2015; 1853:513-521.
8. Newton AC. Protein kinase C: Perfectly balanced. Crit Rev Biochem Mol Biol 2018; 53:208-230.
9. Marrocco V, Bogomolovas J, Ehler E, dos Remedios CG, Yu JY, Gao C, et al. PKC and PKN in heart disease. J Mol Cell Cardiol 2019; 128:212-226.
10. Gào X, Schöttker B. Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews. Oncotarget 2017; 8:51888-51906.
11. Wang XP, Yao Y, Li YX, Guo SJ, Li YJ, Zhang GQ. Experimental study on the effect of luteolin on the proliferation, apoptosis and expression of inflammation-related mediators in lipopolysaccharide-induced keratinocytes. Int J Immunopathol Pharmacol 2023; 37: 3946320231169175.
12. Madouri F, Chenuet P, Beuraud C, Fauconnier L, Marchiol T, Rouxel N, et al. Protein kinase Cθ controls type 2 innate lymphoid cell and T2 responses to house dust mite allergen. J Allergy Clin Immunol 2017; 139:1650-1666.
13. Fiore PF, Benedetti A, Sandonà M, Madaro L, De Bardi M, Saccone V, et al. Lack of PKCθ promotes regenerative ability of muscle stem cells in chronic muscle injury. Int J Mol Sci 2020; 21: 932-945.
14. Song YN, Lee JW, Ryu HW, Lee JK, Oh ES, Kim DY, et al. Black ginseng extract exerts potentially anti-asthmatic activity by inhibiting the protein kinase Cθ-mediated IL-4/STAT6 signaling pathway. Int J Mol Sci 2023; 24:11970-11985.
15. Jiang L, Chi CH, Yuan F, Lu MQ, Hu DQ, Wang L, et al. Anti-inflammatory effects of anemonin on acute ulcerative colitis via targeted regulation of protein kinase C-θ. Chin Med 2022; 17:39-50.
16. Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, et al. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells. Sci Rep 2017; 7: 6594-6607.
17. Pu JL, Huang ZT, Luo YH, Mou T, Li TT, Li ZT, et al. Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway. Hepatobiliary  Pancreat Dis Int 2021; 20:352-360.
18. Wang GG, Lu XH, Ding M, Tang WT, Li W, Zhao X, et al. [Protective effects of luteolin preconditioning on rat liver under ischemia/reperfusion]. Sheng Li Xue Bao 2011; 63:177-183.
19. Yu HC, Bai L, Yang ZX, Qin HY, Tao KS, Han H, et al. Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLD. Sci Rep 2016; 6: 32226-32235.
20. Wang YC, Yang Y, Wang M, Wang SH, Jeong JM, Xu L, et al. Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med 2021; 13: eabb6576-6596.
21. Ito Y, Hosono K, Amano H. Responses of hepatic sinusoidal cells to liver ischemia-reperfusion injury. Front Cell  Dev Biol 2023; 11: 1171317-1171334.
22. Ahmed O, Robinson MW, O’Farrelly C. Inflammatory processes in the liver: Divergent roles in homeostasis and pathology. Cell  Mol Immunol 2021; 18:1375-1386.
23. Jiang Y, He XX, Simonaro CM, Yi B, Schuchman EH. Acid ceramidase protects against hepatic ischemia/reperfusion injury by modulating sphingolipid metabolism and reducing inflammation and oxidative stress. Front Cell Dev Biol 2021; 9: 633657-6336669.
24. Li ZX, Wang Y, Zhang Y, Wang X, Gao BQ, Li Y, et al. Protective effects of fisetin on hepatic ischemia-reperfusion injury through alleviation of apoptosis and oxidative stress. Arch Med Res 2021; 52:163-173.
25. Zhu CL, Shi SH, Jiang P, Huang XJ, Zhao JX, Jin Y, et al. Curcumin alleviates hepatic ischemia-reperfusion injury by inhibiting neutrophil extracellular traps formation. J Invest Surg 2023; 36: 2164813.
26. Yang H, Huang ZT, Luo YH, Lei DL, Yan P, Shen A, et al. TRIM37 exacerbates hepatic ischemia/reperfusion injury by facilitating IKKγ translocation. Mol Med 2023; 29: 62-78.
27. Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Rad Biol Med 2018; 117:76-89.
28. Catanzaro R, Zerbinati N, Solimene U, Marcellino M, Mohania D, Italia A, et al. Beneficial effect of refined red palm oil on lipid peroxidation and monocyte tissue factor in HCV-related liver disease: a randomized controlled study. Hepatobiliary Pancreat Dis Int 2016; 15:165-172.
29. Xu GP, Wang XL, Xiong YX, Ma XP, Qu L. Effect of sevoflurane pretreatment in relieving liver ischemia/reperfusion-induced pulmonary and hepatic injury. Acta Cir Bras 2019; 34: e201900805.
30. Kammouni W, Wood H, Jackson AC. Lyssavirus phosphoproteins increase mitochondrial complex I activity and levels of reactive oxygen species. J Neurovirol 2017; 23:756-762.
31. Zhang XY, Yu YH, Lei HY, Cai YF, Shen J, Zhu P, et al. The Nrf-2/HO-1 signaling axis: A ray of hope in cardiovascular diseases. Cardiol Res Pract 2020; 2020:5695723.
32. Yu QW, Chen SY, Tang HW, Zhang XD, Tao RL, Yan ZP, et al. Veratric acid alleviates liver ischemia/reperfusion injury by activating the Nrf2 signaling pathway. Int Immunopharmacol 2021; 101: 108294-1082302.
33. Zhao Y, Kong GY, Pei WM, Zhou B, Zhang QQ, Pan BB. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway. Eur Cytokine Netw 2019; 30:88-97.
34. Chen QY, Wang GG, Li W, Jiang YX, Lu XH, Zhou PP. Heme oxygenase-1 promotes delayed wound healing in diabetic rats. J Diabetes Res 2016; 2016: 9726503-9726512.
35. Bao LP, Li JS, Zha DQ, Zhang L, Gao P, Yao T, et al. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-κB pathways. Int Immunopharmacol 2018; 54:245-253.
36. Nitti M, Ivaldo C, Traverso N, Furfaro AL. Clinical significance of heme oxygenase 1 in tumor progression. Antioxidants 2021; 10: 789-818.
37. Xie B, Cheng B, He L, Liu Y, He N. HO-1 attenuates testicular ischaemia/reperfusion injury by activating the phosphorylated C-jun-miR-221/222-TOX pathway. Heliyon 2024; 10:e24579-24591.
38. Sadeghi M, Fathi M, Navashenaq JG, Mohammadi H, Yousefi M, Hojjat-Farsangi M, et al. The prognostic and therapeutic potential of HO-1 in leukemia and MDS. Cell Commun Signal 2023; 21:57-77.
39. He N, Sun XN, Hu ZH, Wang FF, Zhang Y, Chen XW, et al. HO-1 protects remnant liver against dysfunction after major hepatectomy in humans. J Investig Surg 2022; 35:1163-1169.
40. Yang WC, Wang YX, Zhang CG, Huang YZ, Yu JX, Shi L, et al. Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and Nrf2/HO-1/GPX4 activation. Front Pharmacol 2022; 13: 865689-865699.
41. Zhang XY, Ding M, Zhu P, Huang HL, Zhuang Q, Shen J, et al. New insights into the Nrf-2/HO-1 signaling axis and its application in pediatric respiratory diseases. Oxid Med Cell Longev 2019; 2019: 3214196-3214204.
42. Yoon SH, Kang HB, Kim J, Yoo K, Han SJ. Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice. Sci Rep 2022; 12: 18158-18168.
43. Kaltenmeier C, Wang RH, Popp B, Geller D, Tohme S, Yazdani HO. Role of immuno-inflammatory signals in liver ischemia-reperfusion injury. Cells 2022; 11: 2222-2234.
44. Ni M, Zhang J, Sosa R, Kageyama S, Busuttil R, Elaine R, et al. TIM-4+kupffer cells play homeostatic roles in liver ischemia reperfusion injury. Hepatology  2021; 74: 2118–2132.
45. Chen D, Wei L, Chen Z. Prevention of aged liver ischemia reperfusion injury by silencing the expression of liver TNF-α and complement 3 gene in mice. Transplantation 2017; 101:105-105.
46. Yang RH, Song ZX, Wu SQ, Wei Z, Xu Y, Shen XC. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model. Atherosclerosis 2018; 279: 23-31.
47. Morsy MA, Ibrahim YF, Hafez SMNA, Zenhom NM, Nair AB, Venugopala KN, et al. Paeonol attenuates hepatic ischemia/reperfusion injury by modulating the Nrf2/HO-1 and TLR4/MYD88/NF-κB signaling pathways. Antioxidants 2022; 11:1687-1704.
48. Hu XJ, Ding CG, Ding XM, Fan P, Zheng J, Xiang HL, et al. Inhibition of myeloid differentiation protein 2 attenuates renal ischemia/reperfusion-induced oxidative stress and inflammation via suppressing TLR4/TRAF6/NF-kB pathway. Life Sci 2020; 256: 117864.
49. Morsy MA, Abdel-Gaber SA, Rifaai RA, Mohammed MM, Nair AB, Abdelzaher WY. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression. Biomed Pharmacother 2022; 145: 112374-112382.
50. Zhang X, Du QM, Yang Y, Wang JN, Dou S, Liu C, et al. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Biomed Pharmacother 2017; 91:1042-1052.
51. Yu Z, Tong Y, Zhang RLZ, Ding XB, Li Q. Saquinavir ameliorates liver warm ischemia-reperfusion-induced lung injury via HMGB-1-and P38/JNK-mediated TLR-4-dependent signaling pathways. Mediators Inflamm 2017; 2017: 7083528-7083538.
52. Anto NP, Muraleedharan A, Nath PR, Sun ZM, Keasar C, Livneh E, et al. The Peptidyl-Prolyl isomerase, Pin1, associates with Protein Kinase C ? via a critical Phospho-Thr-Pro motif in the V3 regulatory domain. Front Immunol 2023; 14: 1126464-1126478.
53. Al-Sabri MH, Behare N, Alsehli AM, Berkins S, Arora A, Antoniou E, et al. Statins induce locomotion and muscular phenotypes in that are reminiscent of human myopathy: Evidence for the role of the chloride channel inhibition in the muscular phenotypes. Cells 2022; 11:3528-3562.
54. Zaid Y, Senhaji N, Naya A, Fadainia C, Kojok K. PKCs in thrombus formation. Pathol Biol 2015; 63:268-271.
55. Lim PS, Sutton CR, Rao S. Protein kinase C in the immune system: from signalling to chromatin regulation. Immunology 2015; 146:508-522.
56. Xu C, Song YL, Wang ZG, Jiang JZ, Piao YH, Li L, et al. Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO-1 pathways. Immun Inflamm Dis 2021; 9:1406-1417.
 
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 30 June 2024

Files

Share

How to cite

Statistics